March 29, 2024 · Form 4 insider transaction
Kundu Sourav bought 52,900 shares of NextCure, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The option vests in full on the one year anniversary of the grant, March 29, 2025.